Enlasia Pharmaceuticals Private Limited

Enlasia Pharmaceuticals Private Limited - trading in Gurugram, Haryana, India. Directors, charges & compliance details.
CIN U51909HR2018PTC075143 Incorporated 30 July 2018 ROC Delhi HQ Gurugram, Haryana, India
Struck Off Private Limited Company trading
Revenue · FY 2023
₹1.71 Lakh
▲ 139% YoY
Net profit · FY 2023
₹96,165
Net margin 56.1%
EBITDA · FY 2023
₹96,165
EBITDA margin 56.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Enlasia Pharmaceuticals Private Limited

Data last updated:

Enlasia Pharmaceuticals Private Limited was a private limited company based in Gurugram, Haryana, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the specialised services segment of the trading and commerce sector. It was incorporated on 30 July 2018.

The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U51909HR2018PTC075143. Its GSTIN is 06AAFCE1278E1ZV (Haryana).

The company had an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Rakesh Mittal and Chhaya Bhatnagar.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Office No. 581/17 Nai Basti Gurugram, Haryana, India – 122001.

As per the financials filed for FY 2023, the company reported a revenue of ₹1.71 Lakh, a growth of 139% compared to the previous year. For the same year it recorded a net profit of ₹96,165 (net margin 56.1%) and EBITDA of ₹96,165 (EBITDA margin 56.1%). Revenue has grown at a compounded annual rate (CAGR) of 67% over three years.

Company details

CIN U51909HR2018PTC075143
Registration Number 075143
Incorporation Date 30 July 2018
ROC Delhi
Listing Status Unlisted
Company Status Struck Off

Contact details

Enlasia Pharmaceuticals Private Limited's registered office is in Gurugram, Haryana. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Office No. 581/17 Nai Basti Gurugram, Haryana, India – 122001
  • Industry
    Trading, Specialty, Wholesale

To see the full contact details of Enlasia Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Enlasia Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Enlasia Pharmaceuticals Private Limited

FY 2024 filings available

Enlasia Pharmaceuticals Private Limited reported revenue of ₹1.71 Lakh (up 139% YoY) for FY 2023.

Revenue · FY 2023
₹1.71 Lakh ▲ 139%
Net profit · FY 2023
₹96,165 margin 56.1%
EBITDA · FY 2023
₹96,165 margin 56.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 139%
3 years · compounded
▲ 67%
EBITDA CAGR growth
1 year
▲ 420%
3 years · compounded
▲ 117%

Revenue has grown at a compounded annual rate (CAGR) of 67% over three years, including 139% growth in the latest year. EBITDA rose 420% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹96,165
Profit Before Tax
Tax Expense
Net Profit (PAT)₹96,165
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin56.1%
Net Profit Margin56.1%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Enlasia Pharmaceuticals Private Limited, buy the company report.

Board of directors of Enlasia Pharmaceuticals Private Limited

Enlasia Pharmaceuticals has 2 directors on record. No former directors are listed.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Rakesh MittalDirector30 Jul 20188 Years 3 MonthsAs last reported
Chhaya BhatnagarDirector30 Jul 20188 Years 3 MonthsAs last reported

Peer comparison

Enlasia Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Omkam Pharmaceuticals Private Limited₹1.75 Lakh (FY 2025)-26.0%New Delhi, Delhi, India
Kokban Ayurvedic Pharmaceuticals Private Limited₹1.74 Lakh (FY 2018)7.0%Mumbai, Maharashtra, India
Ocecure Pharmaceuticals Private Limited₹1.74 Lakh (FY 2022)-51.0%East Mumbai, Maharashtra, India
Cipa Pharmaceuticals Private Limited₹1.73 Lakh (FY 2025)-38.0%Udaipur, Rajasthan, India
Logyesthesia Pharmaceuticals Private Limited₹1.72 Lakh (FY 2016)Nanded, Maharashtra, India
Enlasia Pharmaceuticals Private Limitedthis company₹1.71 Lakh (FY 2023)₹96,16556.1%139.0%Gurugram, Haryana, India
Alphonce Pharmaceuticals Private Limited₹1.71 Lakh (FY 2023)Patna, Bihar, India
T.C.L. Pharmaceuticals Limited₹1.71 Lakh (FY 2025)Jaipur, Rajasthan, India
Rivoma Pharmaceuticals Private Limited₹1.7 Lakh (FY 2025)-62.0%Chandrapur, Maharashtra, India
Doctor Choice Pharmaceuticals Private Limited₹1.69 Lakh (FY 2025)-58.0%Faridabad, Haryana, India
Raquel Pharmaceuticals Private Limited₹1.69 Lakh (FY 2020)-88.0%Vadodara, Gujarat, India

To see the full peer comparison of Enlasia Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Enlasia Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Enlasia Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
06AAFCE1278E1ZVHaryanaActive29 Nov 2019

To see the full GST registrations and return filing status of Enlasia Pharmaceuticals Private Limited, buy the company report.

Recent activity

Enlasia Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Chhaya Bhatnagar was appointed as Director on 30 Jul 2018.

AGM
Enlasia Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Enlasia Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Appointed
Chhaya Bhatnagar was appointed as Director.
Appointed
Rakesh Mittal was appointed as Director.
Incorporation
30 Jul 2018
Enlasia Pharmaceuticals Private Limited was registered on 30 Jul 2018 with Roc Delhi & aged 8 years 3 months as per MCA records.

Frequently asked questions

Enlasia Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Enlasia Pharmaceuticals was a private limited company based in Gurugram, Haryana, India. The company worked in specialty, within the trading industry. It was incorporated on 30 July 2018 and is registered under CIN U51909HR2018PTC075143. The company has been struck off by the Registrar of Companies and is no longer operational.

Enlasia Pharmaceuticals had 2 directors:

The CIN (Corporate Identification Number) of Enlasia Pharmaceuticals is U51909HR2018PTC075143. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Enlasia Pharmaceuticals is at Office No. 58117 Nai Basti Gurugram, Haryana, India – 122001.

Enlasia Pharmaceuticals was incorporated on 30 July 2018. It is registered with the Registrar of Companies, Delhi.

The latest financial statements of Enlasia Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Enlasia Pharmaceuticals is 06AAFCE1278E1ZV, registered in Haryana.

Enlasia Pharmaceuticals operated in the trading industry, in the specialty segment. It worked in this industry before it was struck off.

The peers of Enlasia Pharmaceuticals by revenue are Omkam Pharmaceuticals Private Limited, Kokban Ayurvedic Pharmaceuticals Private Limited, Ocecure Pharmaceuticals Private Limited, Cipa Pharmaceuticals Private Limited, Logyesthesia Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Chhaya Bhatnagar was appointed as Director on 30 Jul 2018. Rakesh Mittal was appointed as Director on 30 Jul 2018.